ArticleBMC medicine2024

TBK1, a prioritized drug repurposing target for amyotrophic lateral sclerosis: evidence from druggable genome Mendelian randomization and pharmacological verification in vitro.

Qing-Qing Duan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.